Search bioRxivSearch

bioRxiv · 10.1101/2020.07.09.195743

Activity throughout the lichen phylogeny indicates a focus on regulation of specialized metabolites

Abstract

Lichens are complex multi-microorganismal communities that have evolved the ability to share their thalli with a variety of microorganisms. As such, the lichenized fungus becomes a scaffold for a variety of microbes and occasionally insects. Lichens are known to produce a plethora of unique specialized (secondary) compounds that demonstrate biological activities, including antibacterial, antifungal, antiviral, and antioxidant, that may provide protection from harmful microbes. The longevity of lichens and their robustness, despite a close association with diverse microbes, provides an interesting study system to view the role of specialized metabolites in managing a microbial community. The objective of this study was to identify the effects lichens may have on basic functions of fungi in and on the lichens. We tested chemical extracts from lichen species across the phylogenetic tree for their effects on sporulation, hyphal growth and specialized metabolite production, using two well-studied mycotoxigenic fungi (Aspergillus parasiticus (aflatoxin) and Fusarium graminearum (trichothecenes) whose functions are easily observed in culture. By far the most prevalent activity among the 67 lichens we tested were effects on accumulation of fungal specialized metabolites, which appeared in 92% of the lichen species analyzed across the phylogeny, although the lichen extracts were also active against fungal sporulation (31%) and growth (12%). The consistent presence of this regulatory activity for specialized metabolism indicates this is an important aspect of lichen integrity. Interestingly, inhibition of accumulation of products of the aflatoxin biosynthetic pathway was the predominant activity, whereas increased accumulation versus decreased accumulation of the production of trichothecenes were about equal. This suggests multiple mechanisms for addressing fungal processes. We performed microbiome analysis of four lichen species and identified oomycetes as members of the microbiomes. Although a small sample size was used for comparing microbiomes, the lichen species exhibiting lower effects on the test fungi had a higher number of OTUs. Members of the lichen community may manipulate specialized metabolism of the essential and transient fungal members and thus attenuate negative interactions with the incumbent fungi or, alternatively, may support the production of compounds by beneficial fungal partners. The ability to control the microbiome by specialized metabolites as opposed to controlling by reducing sporulation of growth, can be effective, discerning, and energetically thrifty, allowing the microbiome members to be controlled without being invasive. Elucidating the role of specialized metabolites in the mechanisms underlying lichen assembly and function has important implications for understanding not only lichen community assembly but for revealing the fundamental processes in microbiota in general.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Ludmila V. Roze, Maris Laivenieks, Kristi Gdanetz, John E. Linz, Alan M. Fryday, Frances Trail. 2020-07-09. Activity throughout the lichen phylogeny indicates a focus on regulation of specialized metabolites. https://doi.org/10.1101/2020.07.09.195743

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

A conserved cysteine-histidine-glutamate metal site identifies DUF501 (Rv1025), an essential uncharacterised protein family of Mycobacterium tuberculosis, as a candidate metalloenzyme and drug target

A substantial fraction of the Mycobacterium tuberculosis proteome remains functionally uncharacterised. Rv1025, a 155-residue protein carrying the domain of unknown function DUF501 (Pfam PF04417), is essential by transposon mutagenesis and vulnerable by CRISPR interference, an attractive but neglected drug target, yet has never been functionally described. The family (4,370 proteins, no Gene Ontology term, no solved structure) is uncharacterised across all organisms and essential in three Actinobacterial genera. A Foldseek search of the AlphaFold model against complete structural databases finds no significant homolog, indicating a novel fold. The operon eno-divIC-Rv1025-ppx2 is conserved across the Actinobacteria phylum, yet AlphaFold-Multimer finds no direct complex between Rv1025 and its neighbour DivIC. Instead, conservation across 8,700 homologous sequences reveals a near-invariant Cys113-His115-Glu59 cluster forming a pocket. Holo AlphaFold3 predictions with Zn, Fe and Mn confidently place a divalent metal on this triad at 2.25-2.47 A; mutating the triad relocates the metal, and an independent backbone-geometry predictor recovers the same site, confirming specificity. The triad is universal across the family: present in all 1,472 near-complete bacterial sequences of the Pfam alignment, with no non-conservative substitution among the 2,228 sequences examined, a defining feature of bacterial DUF501 rather than a mycobacterial peculiarity. We propose that DUF501 is a metal-binding protein and candidate metalloenzyme, the first functional hypothesis for this family, whose conserved, essential metal pocket is a promising drug target. As the predictions build on a conservation-defined site within a fully computational study, they are supportive rather than proof of metal occupancy and warrant experimental validation.

microbiology

Mycoplasmal endosymbionts of Trichomonas vaginalis are associated with reduced risk for Chlamydia trachomatis endometrial infection in asymptomatic, coinfected, women.

Trichomonas vaginalis is a protozoan parasite that causes trichomoniasis, the most common curable non-viral sexually transmitted infection, and Chlamydia trachomatis is a bacterial pathogen that can ascend to the upper genital tract and cause pelvic inflammatory disease, infertility, and ectopic pregnancy. T. vaginalis harbors bacterial endosymbionts, including Candidatus Malacoplasma girerdii, an obligate symbiont, and Metamycoplasma hominis, which can live freely or symbiotically. In a 16S rRNA sequencing study of the cervicovaginal microbiome of women at high risk for chlamydial infection, Ca. M. girerdii abundance was one of 13 features predicting lack of chlamydial spread to the endometrium, despite no direct association between T. vaginalis infection and reduced chlamydial ascension. Investigating the relationship between these microorganisms further, we found that T. vaginalis vaginal abundance correlated positively with chlamydial burden in women whose infection was confined to the cervix, while a nonsignificant inverse relationship was seen in women with endometrial spread. Among participants with high chlamydial burden, Ca. M. girerdii was detected exclusively in women without endometrial infection. Both endosymbionts trended toward more frequent detection, and higher abundance, in coinfected women without endometrial spread, while M. hominis abundance correlated strongly with T. vaginalis burden in this group. These findings suggest that mycoplasmal endosymbionts of T. vaginalis, rather than T. vaginalis itself, are microbial factors limiting chlamydial ascension, and point to a three-way interaction between parasite, endosymbiont, and bacterial pathogen that shapes upper genital tract C. trachomatis infection risk.

microbiology

Understanding the physiological alterations of Vibrio cholerae upon exposure to L-ascorbic acid

The scourge of cholera remains a major global public health threat. It affects up to 4 million people worldwide and causes tens of thousands of deaths each year. The disease is experiencing a concerning resurgence in many parts of Africa, the Middle East, and Asia. To effectively tackle cholera and circumvent rising antimicrobial resistance, targeted biological and preventive approaches, complementing traditional rehydration, are urgently needed. In this regard, our group has demonstrated the efficacy of L-ascorbic acid in controlling the growth and pathogenesis of Vibrio cholerae in vitro. The present work further provides a mechanistic elucidation of the L-ascorbic acid-mediated physiological changes in V. cholerae and also bolsters such a non-antibiotic approach to control cholera.

microbiology